In a rare display of bipartisanship, the 24 members of the Senate Finance Committee sent a letter to the Centers for Medicare and Medicaid Services urging the agency to reconsider a proposal to limit protected class status for certain medications under Medicare Part D. “We are very concerned this change will lead to decreased access to medication, especially for those beneficiaries afflicted by mental health problems,” the senators wrote. “These vulnerable individuals rely on multiple medications to control and treat their illnesses. Unfortunately, over the course of treatment, certain medications may cause undesired side effects or become ineffective. As a result, certain beneficiaries must have a wide range of treatment options available. By limiting the number and type of medications offered under a Part D plan, a beneficiary may be forced to rely, if only temporarily, on medication that simply does not work or results in adverse side effects.” Click below to view the letter.
Write something about yourself. No need to be fancy, just an overview.